The Lyfebulb-Novo Nordisk Innovation Summit 2017 will recognize and empower international Patient Entrepreneurs with big ideas that disrupt the future of diabetes management. Patient Entrepreneurs have a unique ability to create value-adding disease management solutions beyond therapy. The aim is to support patient-driven innovation and laser-focus on improving the quality of life for those living with diabetes.

Two NHS trusts in the North West of England have taken the lead in breaking down barriers between diagnostic departments and frontline clinical staff, in a move that healthcare professionals say is changing how they can view and diagnose patients, and that is improving collaboration between hospitals across the region.

Humans experience a range of emotions in response to products and experiences on a daily basis. Shoppers may get excited for certain brands and then overwhelmed by choices. Audience members may oscillate between apathy and engagement during performances. Children can become frustrated, bored, or entertained while learning a new subject. Using wearable stress sensors, analytics, and other technologies, MIT Media Lab spinout mPath is able to pinpoint the exact moment consumers feel these subconscious responses.

Roche (SIX: RO, ROG; OTCQX: RHHBY) and mySugr have signed an agreement under which Roche acquired all shares of mySugr GmbH. Counting more than one million users globally, mySugr is one of the leading mobile diabetes platforms in the market and will become an integral part of Roche's new patient-centered digital health services platform in diabetes care.

St Michael’s Hospital achieved a significant milestone in East Ireland's journey towards digitally enabled healthcare last week by going live with an electronic patient management system in its Emergency Department (ED). The system went live on 15th June, effectively making the ED paper-lite as the core clinical and administrative processes moved from being paper-based to electronic with no disruption to patient care.

Tejre Tobiassen suffered from a cardio arrest. During his rehabilitation, Tejre came up with the idea of an intelligent wearable that could help prevent cardio arrest and other life threatening incidents. A year after his cardio arrest, he founded ContinYou. The product is ready for sale in Norway.

ZCube, Research Venture of the pharmaceutical group Zambon, announced the second edition of Open Accelerator, the made-in-Italy fast track acceleration program dedicated to projects in life science fields. Open Accelerator is a 12-steps program providing training to international researchers, scientists and aspiring entrepreneurs that following a selection could receive a seed investment of up to a maximum of 100.000 EUR for each project.